Agios Pharmaceuticals Inc (NAS:AGIO)
$ 59.04 0.02 (0.03%) Market Cap: 3.37 Bil Enterprise Value: 2.42 Bil PE Ratio: 5.20 PB Ratio: 2.07 GF Score: 37/100

Agios Pharmaceuticals Inc Virtual Investor Webcast to Review Mitapivat Clinical Data Presented at EHA Annual Congress Transcript

Jun 12, 2020 / 11:30AM GMT
Release Date Price: $47.14 (-6.97%)
Kendra Adams
Agios Pharmaceuticals, Inc. - VP of External Communications & IR

Good morning, everyone. We're going to get started here. I'm going to turn it over to Jackie. For our sell-side friends, if you have not e-mailed myself or Holly and would like to get in the lineup for the Q&A, will you just shoot us an e-mail now and we'll take questions as folks have e-mailed us and then queued up. So with that, Jackie, why don't I turn it over to you? Jackie, we can't hear you just make sure you're unmuted.

Jacqualyn A. Fouse
Agios Pharmaceuticals, Inc. - CEO & Director

Can you hear me?

Kendra Adams
Agios Pharmaceuticals, Inc. - VP of External Communications & IR

Part of it. Thank you. Yes, go ahead.

Jacqualyn A. Fouse
Agios Pharmaceuticals, Inc. - CEO & Director

Everybody. Can I get some thumbs up that you can hear me. Okay. Perfect. Thank you. Good morning, everybody. Why don't I to start off our e virtual investor webcast this morning. So thanks

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot